Saturday 17 October 2026
Export SHPH’s income statement to Excel — free account
Shuttle Pharmaceuticals Holdings, Inc.
SHPH Healthcare Drug Manufacturers Specialty & Generic
In the quarter to June 2026, EPS grew 90.6% and free cash flow grew 82.0%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
5.08
0.49
−8.80%
Follow SHPH
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(27,170.81%) | (791.04%) | (326.36%) | (90.05%) | |
| (507.78%) | (180.58%) | (126.42%) | (72.47%) | ||
ROIC |
0.00% | (387.83%) | (309.75%) | (36.73%) | |
Return on Tangible Assets |
(811.44%) | 157.41% | 185.73% | 334.30% | |
Average Days of Receivables |
— | — | — | — | |
Free Cash Flow per Share |
(50.13) | (58.07) | (18.76) | (6.57) | |
Free Cash Flow |
(11.20) | (9.51) | (9.44) | (6.67) | |
Capital Expenditures |
— | (0.03) | (0.07) | (0.08) | |
| Other line items | |||||
Cash ROIC |
(320.99%) | (367.51%) | (212.78%) | (34.60%) | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
(184.53) | (168.31) | (157.50) | — | |
Operating CF/Net income |
1.05 | 0.81 | 0.87 | 0.64 | |
Depreciation/Fixed assets |
2.78 | 20.35 | 60.74 | 105.33 | |
Capex/Depreciation |
0.00 | (0.09) | (0.07) | (0.05) | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(50.13) | (57.89) | (18.62) | (6.49) | |
Capex per Share |
0.00 | (0.19) | (0.13) | (0.08) | |
Capex to Sales |
— | 0.00 | 0.00 | 0.00 |
Columns are period end dates · fundamentals updated 2 Oct 2026